Mostrar el registro sencillo del ítem

dc.contributor.authorPernas, Maria 
dc.contributor.authorCasado, Concepcion 
dc.contributor.authorArcones, Carolina 
dc.contributor.authorLlano, Anuska
dc.contributor.authorSanchez-Merino, Victor 
dc.contributor.authorMothe, Beatriz
dc.contributor.authorVicario, José L
dc.contributor.authorGrau, Eulalia
dc.contributor.authorRuiz, Lidia
dc.contributor.authorSánchez, Jorge
dc.contributor.authorTelenti, Amalio
dc.contributor.authorYuste-Herranz, Maria Eloisa
dc.contributor.authorBrander, Christian
dc.contributor.authorLopez-Galindez, Luis Cecilio 
dc.date.accessioned2018-12-12T15:01:22Z
dc.date.available2018-12-12T15:01:22Z
dc.date.issued2012-02-24
dc.identifier.citationPLoS One. 2012;7(2):e31928es_ES
dc.identifier.issn1932-6203es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/6828
dc.description.abstractOBJECTIVE: To study the causes for the lack of clinical progression in a superinfected HIV-1 LTNP elite controller patient. METHODOLOGY AND PRINCIPAL FINDINGS: We studied host genetic, virological and immunological factors associated with viral control in a SI long term non progressor elite controller (LTNP-EC). The individual contained both viruses and maintained undetectable viral loads for >20 years and he did not express any of the described host genetic polymorphisms associated with viral control. None of four full-length gp160 recombinants derived from the LTNP-EC replicated in heterologous peripheral blood mononuclear cells. CTL responses after SI were maintained in two samples separated by 9 years and they were higher in breadth and magnitude than responses seen in most of 250 treatment naïve patients and also 25 controller subjects. The LTNP-EC showed a neutralization response, against 4 of the 6 viruses analyzed, superior to other ECs. CONCLUSIONS: The study demonstrated that a strong and sustained cellular and humoral immune response and low replicating viruses are associated with viral control in the superinfected LTNP-EC.es_ES
dc.description.sponsorshipThis work was supported by grants SAF 2007-61036 and SAF 2010-17226, by Fundacion para la Investigacion y Prevencion del SIDA en España (FIPSE) grants 36558/06, 36641/07, 36779/08, 360766/09 and 360737/09, and by the United States National Institute of Health NIH-NIAID contract N01-AI-30024. Support by the Red Temática Cooperativa de Investigación en SIDA (Red de grupos 173) of the Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss) is appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library of Science (PLOS) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAntiviral Agents es_ES
dc.subject.meshCD4-Positive T-Lymphocytes es_ES
dc.subject.meshChemokines es_ES
dc.subject.meshDisease Progression es_ES
dc.subject.meshGenotype es_ES
dc.subject.meshHIV-1 es_ES
dc.subject.meshHaplotypes es_ES
dc.subject.meshHumans es_ES
dc.subject.meshImmune System es_ES
dc.subject.meshLeukocytes, Mononuclear es_ES
dc.subject.meshLikelihood Functions es_ES
dc.subject.meshMale es_ES
dc.subject.meshMutation es_ES
dc.subject.meshPolymorphism, Genetic es_ES
dc.subject.meshRecombinant Proteins es_ES
dc.subject.meshTime Factors es_ES
dc.subject.meshViral Load es_ES
dc.subject.meshVirus Replication es_ES
dc.titleLow-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controlleres_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID22384103es_ES
dc.format.volume7es_ES
dc.format.number2es_ES
dc.format.pagee31928es_ES
dc.identifier.doi10.1371/journal.pone.0031928es_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España) 
dc.contributor.funderFundación para la Investigación y la Prevención del Sida en España 
dc.contributor.funderNational Institutes of Health (Estados Unidos) 
dc.contributor.funderInstituto de Salud Carlos III 
dc.description.peerreviewedes_ES
dc.identifier.e-issn1932-6203es_ES
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0031928es_ES
dc.identifier.journalPloS onees_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF-2007-61036es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF-2010-17226es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional